MRSN Stock Summary and Trading Ideas (Mersana Therapeutics | NASDAQ:MRSN)

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.

Mersana Therapeutics trades on the NASDAQ stock market under the symbol MRSN.

As of May 13, 2024, MRSN stock price declined to $2.69 with 186,968 million shares trading.

MRSN has a beta of 0.77, meaning it tends to be less sensitive to market movements. MRSN has a correlation of 0.00 to the broad based SPY ETF.

MRSN has a market cap of $324.16 million. This is considered a Small Cap stock.

Last quarter Mersana Therapeutics reported $9 million in Revenue and -$.16 earnings per share. This beat revenue expectation by $745,000 and exceeded earnings estimates by $.02.

In the last 3 years, MRSN stock traded as high as $15.41 and as low as $.80.

The top ETF exchange traded funds that MRSN belongs to (by Net Assets): VTI, XBI, IWM, VXF, VTWO.

MRSN has underperformed the market in the last year with a price return of -66.7% while the SPY ETF gained +28.0%. MRSN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -30.7% and -8.5%, respectively, while the SPY returned +4.4% and +2.6%, respectively.

MRSN support price is $2.57 and resistance is $2.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRSN stock will trade within this expected range on the day.